|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Kinetics of disease progression and host response in a rat model of bubonic plague 显示文摘 | Sebbane F Gardner D Long D | 2005 | Am J Pathol2005，166，5： | 1 |
| 2 | Mining probabilistic automata:A statistical view of sequential pattern mining显示文摘 | Jacquemont S Jacquenet F Sebban M | 2009 | Mach Learn2009，75，： | 1 |
| 3 | The pmrF polymyxin-resistance operon of Yersinia pseudotuberculosis is upregulated by the PhoP-PhoQ two-component system but not by PmrA-PmrB,and is not required for virulence显示文摘 | Marceau M Sebbane F Ewann F | 2004 | Microbiology2004，150，12： | 1 |
| 4 | Efficacy and safety of the combination of rituximab, fludarabine, and mitox- antrone for rituximab ~ naive, recurrent/refractory follicular non -Hodgkin lymphoma with high tumor burden: a multicenter phase 2 trial by the Groupe dEtude des Lymphomes de l'Adulte (GELA) and Groupe Ouest Est des Leucemies et Autres Mala- dies du Sang (GOELAMS) 显示文摘 | Morschhauser F Mounier N Sebban C | 2010 | Cancer2010，116，18： | 1 |
| 5 | The international prognostic index correlates to survival in patients with aggressive lymphoma in relapse:analysis of the PARMA trial显示文摘 | Blay J Gomez F Sebban C | 1998 | Blood1998，92，10： | 1 |
| 6 | Protection against Yersinia pseudotuberculosis infection conferred by a Lactococcus lactis mucosal delivery vector secreting LcrV显示文摘 | DANIEL C SEBBANE F POIRET S | 2009 | Vaccine2009，27，8： | 1 |
| 7 | The Yersinia pseudotuberculosis Yut protein, a new type of urea transporter homologous to eukaryotic channels and functionally interchangeable in vitro with the Helicobacter pylori UreI protein 显示文摘 | Sebbane F Bury-Mone S Cailliau K | 2002 | Mol Microbiol2002，45，4： | 1 |
| 8 | Efficacy and safety of the combination of rituximab,fludarabine,and mitoxantrone for rituximab-naive,recurrent/refractory follicular non-Hodgkin lymphoma with high tumor burden:a multicenter phase 2 trial by the Groupe d' Etude des Lymphomes de I' Adulte(GELA)and Groupe Ouest Est des Leucémies et Autres Maladies du Sang(GOELAMS)显示文摘 | MORSCHHAUSER F MOUNIER N SEBBAN C | 2010 | Cancer2010，116，18： | 1 |
| 9 | Role of the Yersinia pestis plasminogen activator in the incidence of distinct septicemic and bubonic forms of flea-home plague显示文摘 | Sebbane F Jarrett CO Gardner D | 2006 | Proc Natl Acad Sci USA2006，103，14： | 1 |
| 10 | 595 nm pulse dye laser therapy for viral warts : a single - blind randomized comparative study versus placebo 显示文摘 | Passeron T Sebban K Mantoux F | 2007 | Ann Dermatol Venereol2007，134，2： | 1 |
| 11 | Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients显示文摘 | Bastion Y Sebban C Berger F | 1997 | J Clin Oncol1997，15，4： | 1 |
| 12 | Incidence,predictive factors,and outcome of lymphoma transformation in follicular lymphoma patients显示文摘 | Bastion Y Sebban C Berger F | | 0，，： | 1 |
| 13 | The International Prognostic Index correlates to survival in patients with aggressive lymphoma in relapse:analysis of the PARMA trial显示文摘 | Blay JY Gomes F Sebban C et a | 1998 | Blood1998，92，： | 1 |
| 14 | Incidence,predictive factors and outcome of lymphoma transformation in follicular lymphoma patients显示文摘 | Bastion Y Sebban C Berger F | 1997 | J Clin Oncol1997，15，3： | 1 |
| 15 | 595 nm pulse dye laser therapy for viral warts:a single-blind randomized comparative study versus placebo显示文摘 | Passeron T Sebban K Mantoux F | | 0，，02： | 1 |
| 16 | Poor vector competence of fleas and the evolution of hypervirulence in Yersinia pestis 显示文摘 | Lorange EA Race BL Sebbane F | 2005 | J Infect Dis2005，191，11： | 1 |
| 17 | The international prognostic index correlates to survival in patients with aggressive lymphoma in relapse: analysis of the PARMA trial 显示文摘 | Blay J Y Gomez F Sebban C | 1998 | Blood1998，92，10： | 1 |
| 18 | The Yersinia pseudotuberculosis Yut protein,a new type of urea transporter homologous to eukaryotic channels and functionally interchangeable in vitro with the Helicobacter pylori UreI protein显示文摘 | Sebbane F Bury-Mone S Cailliau K | 2002 | Mol Microbiol2002，45，4： | 1 |
| 19 | Efficacy and safety of the combination of rituximab, fludarabine, and mitoxantrone for rituximabnaive, recurrent/refractory follicular non-Hodgkin lym phoma with high tumor burden: a multicenter phase 2 trial by the Groupe d'Etude des Lymphornes de l'Adulte (GELA) and Groupe Ouest Est des Leuc6mies et Autres Maladies du Sang (GOELAMS) 显示文摘 | Morschhauser F Mounier N Sebban C | 2010 | Cancer2010，116，18： | 1 |
| 20 | Role of the Yersinia pestis yersiniabactin iron acquisition system in the incidence of flea-borne plague显示文摘 | Sebbane F Jarrett C Gardner D | | 0，，12： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员